Chemo: Testing Who Will Benefit A new report says a genetic profiling test already on the market accurately predicts which breast cancer patients will benefit from chemotherapy -- and who won't. It could help 80,000 women a year make better choices about their treatment. 
Is this a piece of news regarding world politics, sports, business, or science and technology? 